• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of 10 mg and 25 mg of Empagliflozin in Patients With Heart Failure With Reduced Ejection Fraction.

作者信息

Hao Zhengyang, Zhang Yanzhou

机构信息

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Can J Cardiol. 2022 Oct;38(10):1641-1642. doi: 10.1016/j.cjca.2022.05.026. Epub 2022 Jun 9.

DOI:10.1016/j.cjca.2022.05.026
PMID:35691568
Abstract
摘要

相似文献

1
Comparison of 10 mg and 25 mg of Empagliflozin in Patients With Heart Failure With Reduced Ejection Fraction.10毫克与25毫克恩格列净治疗射血分数降低的心力衰竭患者的比较
Can J Cardiol. 2022 Oct;38(10):1641-1642. doi: 10.1016/j.cjca.2022.05.026. Epub 2022 Jun 9.
2
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).恩格列净对射血分数降低的心力衰竭合并 2 型糖尿病或糖尿病前期患者左心室容积的影响（SUGAR-DM-HF）。
Circulation. 2021 Feb 9;143(6):516-525. doi: 10.1161/CIRCULATIONAHA.120.052186. Epub 2020 Nov 13.
3
FDA Expands Empagliflozin Heart Failure Indication.美国食品药品监督管理局扩大恩格列净治疗心力衰竭的适应症。
JAMA. 2022 Apr 5;327(13):1219. doi: 10.1001/jama.2022.3970.
4
Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.对莫内等人的评论。恩格列净改善2型糖尿病和射血分数保留的心力衰竭老年体弱患者的认知障碍。《糖尿病护理》2022年；45:1247 - 1251。
Diabetes Care. 2022 Oct 1;45(10):e150. doi: 10.2337/dc22-0778.
5
Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247-1251.对关于莫内等人的评论的回应。恩格列净改善2型糖尿病合并射血分数保留的心力衰竭的体弱老年人的认知障碍。《糖尿病护理》2022年；45:1247 - 1251。
Diabetes Care. 2022 Oct 1;45(10):e151-e152. doi: 10.2337/dci22-0025.
6
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.恩格列净对伴或不伴糖尿病的心力衰竭患者心血管和肾脏结局的影响：来自 EMPEROR-Reduced 试验的结果。
Circulation. 2021 Jan 26;143(4):337-349. doi: 10.1161/CIRCULATIONAHA.120.051824. Epub 2020 Nov 11.
7
Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study.恩格列净作为附加疗法对因急性失代偿性心力衰竭住院的糖尿病患者的充血和肾功能的影响：一项前瞻性随机对照研究。
Circ Heart Fail. 2021 Mar;14(3):e007048. doi: 10.1161/CIRCHEARTFAILURE.120.007048. Epub 2021 Mar 5.
8
Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF).恩格列净对2型糖尿病或糖尿病前期且射血分数降低的心力衰竭患者（SUGAR-DM-HF）肾脏生化指标和影像学结果的影响。
Circulation. 2022 Jul 26;146(4):364-367. doi: 10.1161/CIRCULATIONAHA.122.059851. Epub 2022 Jul 25.
9
[EMPEROR reduced - empagliflozin in patients with heart failure and reduced ejection fraction].[EMPEROR-Reduced研究——恩格列净用于射血分数降低的心力衰竭患者]
Vnitr Lek. 2021 Winter;67(1):43-47.
10
Research in brief: Empagliflozin for patients with heart failure and preserved ejection fraction.简要研究：恩格列净用于射血分数保留的心力衰竭患者。
Clin Med (Lond). 2022 Jan;22(1):75-76. doi: 10.7861/clinmed.rib.22.1.1.

引用本文的文献

1
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.恩格列净和秋水仙碱在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死后左心室射血分数降低患者中的应用：一项随机、双盲、三臂平行组、对照临床试验的研究方案。
Trials. 2023 Oct 6;24(1):645. doi: 10.1186/s13063-023-07682-6.